-+ 0.00%
-+ 0.00%
-+ 0.00%

*Black Diamond: Clinical Update on Track for 2Q for Phase 2 Trial of Silevertinib in Patients With Non-Classical EGFRm NSCLC

Dow Jones·03/16/2026 20:09:00

Please log in to view news